These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35634290)

  • 1. Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era.
    Vieira VA; Herbert N; Cromhout G; Adland E; Goulder P
    Front Immunol; 2022; 13():886562. PubMed ID: 35634290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant.
    Wilson CC; Brown RC; Korber BT; Wilkes BM; Ruhl DJ; Sakamoto D; Kunstman K; Luzuriaga K; Hanson IC; Widmayer SM; Wiznia A; Clapp S; Ammann AJ; Koup RA; Wolinsky SM; Walker BD
    J Virol; 1999 May; 73(5):3975-85. PubMed ID: 10196293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.
    Yue FY; Cohen JC; Ho M; Rahman AKMN; Liu J; Mujib S; Saiyed A; Hundal S; Khozin A; Bonner P; Liu D; Benko E; Kovacs C; Ostrowski M
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem Cells.
    Miki S; Kawai Y; Nakayama-Hosoya K; Iwabuchi R; Terahara K; Tsunetsugu-Yokota Y; Koga M; Matano T; Kaneko S; Kawana-Tachikawa A
    J Virol; 2022 Mar; 96(6):e0221721. PubMed ID: 35107374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms.
    Winchester R; Pitt J; Charurat M; Magder LS; Göring HH; Landay A; Read JS; Shearer W; Handelsman E; Luzuriaga K; Hillyer GV; Blattner W
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):659-70. PubMed ID: 15167284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIGH-FREQUENCY failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal needs causing maternal NON-ADHERENCE.
    Millar JR; Bengu N; Fillis R; Sprenger K; Ntlantsana V; Vieira VA; Khambati N; Archary M; Muenchhoff M; Groll A; Grayson N; Adamson J; Govender K; Dong K; Kiepiela P; Walker BD; Bonsall D; Connor T; Bull MJ; Nxele N; Roider J; Ismail N; Adland E; Puertas MC; Martinez-Picado J; Matthews PC; Ndung'u T; Goulder P;
    EClinicalMedicine; 2020 May; 22():100344. PubMed ID: 32510047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Initiation of Antiretroviral Therapy Following In Utero HIV Infection Is Associated With Low Viral Reservoirs but Other Factors Determine Viral Rebound.
    Millar JR; Bengu N; Vieira VA; Adland E; Roider J; Muenchhoff M; Fillis R; Sprenger K; Ntlantsana V; Fatti I; Archary M; Groll A; Ismail N; García-Guerrero MC; Matthews PC; Ndung'u T; Puertas MC; Martinez-Picado J; Goulder P
    J Infect Dis; 2021 Dec; 224(11):1925-1934. PubMed ID: 33963757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of early antiretroviral therapy, early life immunity and immune sex differences on HIV disease and posttreatment control in children.
    Herbert NG; Goulder PJR
    Curr Opin HIV AIDS; 2023 Sep; 18(5):229-236. PubMed ID: 37421384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Control of HIV.
    Balasubramaniam M; Pandhare J; Dash C
    J Life Sci (Westlake Village); 2019 Jun; 1(1):4-37. PubMed ID: 31468033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric HIV infection: correlates of protective immunity and global perspectives in prevention and management.
    Goulder PJ; Jeena P; Tudor-Williams G; Burchett S
    Br Med Bull; 2001; 58():89-108. PubMed ID: 11714626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.
    Omondi FH; Chandrarathna S; Mujib S; Brumme CJ; Jin SW; Sudderuddin H; Miller RL; Rahimi A; Laeyendecker O; Bonner P; Yue FY; Benko E; Kovacs CM; Brockman MA; Ostrowski M; Brumme ZL
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries.
    Scarlatti G
    AIDS Rev; 2004; 6(2):67-78. PubMed ID: 15332429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric HIV infection: the potential for cure.
    Goulder PJ; Lewin SR; Leitman EM
    Nat Rev Immunol; 2016 Apr; 16(4):259-71. PubMed ID: 26972723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.
    Berendam SJ; Nelson AN; Goswami R; Persaud D; Haigwood NL; Chahroudi A; Fouda GG; Permar SR
    Curr HIV/AIDS Rep; 2020 Jun; 17(3):237-248. PubMed ID: 32356090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
    Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
    mBio; 2016 May; 7(3):. PubMed ID: 27247230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® Molecules.
    Pollara J; Edwards RW; Jha S; Lam CK; Liu L; Diedrich G; Nordstrom JL; Huffman T; Pickeral JA; Denny TN; Permar SR; Ferrari G
    Front Immunol; 2020; 11():713. PubMed ID: 32373131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.
    Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR
    J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell and T-cell subset distributions and activation influence susceptibility to perinatal HIV-1 infection.
    Gasper MA; Kunwar P; Itaya G; Lejarcegui N; Bosire R; Maleche-Obimbo E; Wamalwa D; Slyker J; Overbaugh J; Horton H; Sodora DL; John-Stewart G; Lohman-Payne B
    AIDS; 2014 May; 28(8):1115-24. PubMed ID: 24752082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.